Jacobs wins UK nuclear planning contract, but thesis unchanged

What happened

Jacobs has been appointed by Great British Energy – Nuclear to provide planning and consenting services for new UK nuclear projects, adding to its record $23.1B backlog. This win aligns with Jacobs' exposure to energy infrastructure and supports its mid-single-digit growth trajectory. However, our DeepValue report maintains a WAIT rating with a $145 fair value, as the stock at ~$138 already discounts strong execution and faces risks from PA Consulting integration, leverage, and backlog cancelability. The nuclear contract is incremental and positive, but it does not materially alter the risk-reward balance given the current valuation. Investors should await a pullback to the ~$120 attractive entry or confirmation of higher-than-guided margins and free cash flow before initiating positions.

Implication

The UK nuclear win adds to Jacobs' credibility and backlog, but the stock's ~20x FY26 P/E already prices in steady growth. Key risks—PA integration, leverage, and backlog convertibility—remain. We recommend waiting for a ~$120 entry or evidence of margin and FCF outperformance before adding.

Thesis delta

The news reinforces the bull case's infrastructure and energy tailwinds but does not alter the central WAIT thesis, which hinges on PA Consulting integration success and margin/FCF delivery. The contract is too small to shift the probability weights materially.